scholarly journals Changes in Sensory Phenomena, Tics, Obsessive–Compulsive Symptoms, and Global Functioning of Tourette Syndrome: A Follow-Up After Four Years

2020 ◽  
Vol 11 ◽  
Author(s):  
Yukiko Kano ◽  
Miyuki Fujio ◽  
Namiko Kaji ◽  
Natsumi Matsuda ◽  
Maiko Nonaka ◽  
...  
2015 ◽  
Vol 226 (1) ◽  
pp. 156-161 ◽  
Author(s):  
Yukiko Kano ◽  
Toshiaki Kono ◽  
Natsumi Matsuda ◽  
Maiko Nonaka ◽  
Hitoshi Kuwabara ◽  
...  

2015 ◽  
Vol 62 ◽  
pp. 141-146 ◽  
Author(s):  
Yukiko Kano ◽  
Natsumi Matsuda ◽  
Maiko Nonaka ◽  
Miyuki Fujio ◽  
Hitoshi Kuwabara ◽  
...  

Author(s):  
Amita Jassi ◽  
Lorena Fernández de la Cruz ◽  
Ailsa Russell ◽  
Georgina Krebs

Abstract Obsessive–compulsive disorder (OCD) and autism spectrum disorder (ASD) frequently co-occur. Standard cognitive behaviour therapy (CBT) for OCD outcomes are poorer in young people with ASD, compared to those without. The aim of this naturalistic study was to evaluate the effectiveness of a novel adolescent autism-adapted CBT manual for OCD in a specialist clinical setting. Additionally, we examined whether treatment gains were maintained at 3-month follow-up. Thirty-four adolescents underwent CBT; at the end of treatment, 51.51% were treatment responders and 21.21% were in remission. At 3-month follow-up, 52.94% were responders and 35.29% remitters. Significant improvements were also observed on a range of secondary measures, including family accommodation and global functioning. This study indicates this adapted package of CBT is associated with significant improvements in OCD outcomes, with superior outcomes to those reported in previous studies. Further investigation of the generalizability of these results, as well as dissemination to different settings, is warranted.


2019 ◽  
Vol 17 (8) ◽  
pp. 703-709 ◽  
Author(s):  
Aribert Rothenberger ◽  
Veit Roessner

: While Behavioral Therapy (BT) should be recommended as the first step in the treatment of OCD as well as TS, medication can be added for augmentation and in certain situations (e.g. family preference, BT not available or feasible) the priority may even reverse. This narrative review is given on the complexity of drug treatment in patients comorbid with obsessive-compulsive disorder (OCD) and Tourette syndrome (TS) and other tic problems. OCD with TS is a co-occurring combination of the two generally delimitable, but in detail, also overlapping disorders which wax and wane with time but have different courses as well as necessities and options of treatment. Distinct subtypes like “tic-related OCD” are questionable. Obsessive-compulsive symptoms (OCS) and tics are frequently associated (OCS in TS up to 90%, tics in OCD up to 37%). Sensory-motor phenomena like urges and just-right feelings reflect some behavioral overlap. The main additional psychopathologies are attention-deficit hyperactivity disorder (ADHD), mood problems and anxiety. Also, hair pulling disorder and skin picking disorder are related to OCD with TS. Hence, the assessment and drug treatment of its many psychopathological problems need high clinical experience, careful planning, and ongoing evaluation/adaptation. Drugs are able to reduce clinical symptoms but cannot cure the disorders, which should be treated in parallel in their own right; i.e. for OCD serotonin reuptake inhibitors (SSRI) and for TS (tics), certain antipsychotics can be successfully prescribed. In cases of OCD with tics, when OCS responds only partially, an augmentation with antipsychotics (recommended: risperidone and aripiprazole) may improve OCS as well as tics. Also, the benzamide sulpiride, an atypical antipsychotics, may be beneficial in treating the combination of OCS, tics and anxious-depressive problems. : Probably, any additional psychopathologies of OCD might attenuate the effectiveness of SSRI on OCS; on the other hand, in cases of OCD with tics, SSRI may reduce not only OCS but also stress sensitivity and emotional problems and thus leading to better selfregulatory abilities, useful to improve tic suppression. : In sum, some clinical guidance can be given, but there remain many uncertainties because of a scarce database for psychopharmacotherapy in OCD with TS.


PEDIATRICS ◽  
1989 ◽  
Vol 83 (6) ◽  
pp. 1054-1054

The Child Psychiatry Branch of the National Institute of Mental Health is seeking patients for a study of obsessive compulsive symptoms accompanying Sydenham's chorea. Eligible patients should have had recent (within 2 months) onset of Sydenham's chorea, continue to have choreic symptoms and be at least 6 years of age. This study will rate obsessive compulsive symptoms and link these symptoms to anti-CNS autoantibodies. Patients will be interviewed by phone or in person (out of town subjects will be asked to travel at our expense to the NIH in Bethesda). Brief follow-up interviews will be conducted every 2 months for one year. Serum samples (5 cc) will be obtained on four separate occasions. There will be no expense to the patient and no remuneration. Please call (301) 496-6081 or write: Dr Susan E. Swedo or Dr Judith L. Rapoport; Child Psychiatry Branch, NIMH, Bldg 10, Room 6N240, 9000 Rockville Pike, Bethesda, MD 20892.


2018 ◽  
Vol 128 (2) ◽  
pp. 596-604 ◽  
Author(s):  
Richard S. Dowd ◽  
Michael Pourfar ◽  
Alon Y. Mogilner

OBJECTIVETourette syndrome (TS) is a complex neuropsychiatric disorder characterized by multiple motor and phonic tics. While pharmacological and behavioral therapy can be effective in most patients, a subset of patients remains refractory to treatment. Increasing clinical evidence from multiple centers suggests that deep brain stimulation (DBS) of the medial thalamus can be effective in many cases of refractory TS.METHODSThe authors retrospectively reviewed outcomes in 13 patients with refractory TS who underwent medial thalamic DBS performed by their team over a 7-year period. Patients were evaluated by a multidisciplinary team, and preoperative objective assessments were performed using the Yale Global Tic Severity Scale (YGTSS) and Yale-Brown Obsessive Compulsive Scale. YGTSS scores were calculated at visits immediately postoperatively and at the most recent follow-up in patients with a minimum of 6 months of postoperative follow-up. Coordinates of the active DBS contacts were calculated and projected onto each patient's pre- and postoperative images.RESULTSPatients showed an average decrease of 37% (p = 0.0063) in the total tic severity at their first postoperative visit. At their latest visit, their scores achieved significance, decreasing from preoperative scores by an average of 50% (p = 0.0014). The average position of the active contact was noted to be at the junction of the posterior ventralis oralis internus/centromedian-parafascicular nuclei. Device-related complications occurred in 2 patients, necessitating additional surgeries. All patients continued to use the system at last follow-up.CONCLUSIONSThe authors' data are consistent with the small but growing body of literature supporting DBS of the ventralis oralis internus/centromedian-parafascicular thalamus as an effective and relatively safe treatment for severe, refractory TS.


2013 ◽  
pp. 50-73 ◽  
Author(s):  
Ygor A. FerrãO ◽  
Pedro G. De Alvarenga ◽  
Ana G. Hounie ◽  
Maria A. De Mathis ◽  
Maria C. De RosáRio ◽  
...  

2020 ◽  
Vol 123 ◽  
pp. 128-135 ◽  
Author(s):  
Tracy Bhikram ◽  
Paul Arnold ◽  
Adrian Crawley ◽  
Elia Abi-Jaoude ◽  
Paul Sandor

Sign in / Sign up

Export Citation Format

Share Document